American Journal of Kidney Diseases

Genotype/Phenotype Correlations in Complement Factor H Deficiency Arising From Uniparental Isodisomy

      We report a male infant who presented at 8 months of age with atypical hemolytic uremic syndrome (aHUS) responsive to plasma therapy. Investigation showed him to have complement factor H (CFH) deficiency associated with a homozygous CFH mutation (c.2880delT [p.Phe960fs]). Mutation screening of the child's parents revealed that the father was heterozygous for this change but that it was not present in his mother. Chromosome 1 uniparental isodisomy of paternal origin was confirmed by genotyping chromosome 1 SNPs. CD46 SNP genotyping was undertaken in this individual and another patient with CFH deficiency associated with chromosome 1 uniparental isodisomy. This showed a homozygous aHUS risk haplotype (CD46GGAAC) in the patient with aHUS and a homozygous glomerulonephritis risk haplotype (CD46AAGGT) in the patient with endocapillary glomerulonephritis. We also showed that FHL-1 (factor H–like protein 1) was present in the patient with aHUS and absent in the patient with glomerulonephritis. This study emphasizes that modifiers such as CD46 and FHL-1 may determine the kidney phenotype of patients who present with homozygous CFH deficiency.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Noris M.
        • Remuzzi G.
        Atypical hemolytic-uremic syndrome.
        N Engl J Med. 2009; 361: 1676-1687
        • Rodriguez de Cordoba S.
        aHUS: a disorder with many risk factors.
        Blood. 2010; 115: 158-160
        • Servais A.
        • Noel L.H.
        • Roumenina L.T.
        • et al.
        Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
        Kidney Int. 2012; 82: 454-464
        • Pickering M.C.
        • Cook H.T.
        Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.
        Clin Exp Immunol. 2008; 151: 210-230
        • Engel E.
        A new genetic concept: uniparental disomy and its potential effect, isodisomy.
        Am J Med Genet. 1980; 6: 137-143
        • Yamazawa K.
        • Ogata T.
        • Ferguson-Smith A.C.
        Uniparental disomy and human disease: an overview.
        Am J Med Genet Part C Semin Med Genet. 2010; 154C: 329-334
        • Fremeaux-Bacchi V.
        • Sanlaville D.
        • Menouer S.
        • et al.
        Unusual clinical severity of complement membrane cofactor protein-associated hemolytic-uremic syndrome and uniparental isodisomy.
        Am J Kidney Dis. 2007; 49: 323-329
        • Schejbel L.
        • Schmidt I.M.
        • Kirchhoff M.
        • et al.
        Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutation.
        Genes Immun. 2011; 12: 90-99
        • Moore I.
        • Strain L.
        • Pappworth I.
        • et al.
        Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4 and with mutations in CFH, CFI, CD46, and C3 in patients with atypical haemolytic uraemic syndrome.
        Blood. 2010; 115: 379-387
        • Schouten J.P.
        • McElgunn C.J.
        • Waaijer R.
        • Zwijnenburg D.
        • Diepvens F.
        • Pals G.
        Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.
        Nucleic Acids Res. 2002; 30: e57
        • Purcell S.
        • Neale B.
        • Todd-Brown K.
        • et al.
        PLINK: a tool set for whole-genome association and population-based linkage analyses.
        Am J Hum Genet. 2007; 81: 559-575
        • Purcell S.
        • Neale B.
        • Todd-Brown K.
        • et al.
        PLINK: a toolset for whole-genome association and population-based linkage analysis.
        Am J Hum Genet. 2007; 81 (PLINK software. Version 1.05) (Accessed June 7, 2013)
        • Hakobyan S.
        • Tortajada A.
        • Harris C.L.
        • Rodriguez de Cordoba S.
        • Morgan B.P.
        Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome.
        Kidney Int. 2010; 78: 782-788
        • Francis N.J.
        • McNicholas B.
        • Awan A.
        • et al.
        A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
        Blood. 2012; 119: 591-601
        • Schwartz G.J.
        • Munoz A.
        • Schneider M.F.
        • et al.
        New equations to estimate GFR in children with CKD.
        J Am Soc Nephrol. 2009; 20: 629-637
        • Ermini L.
        • Goodship T.H.J.
        • Strain L.
        • et al.
        Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.
        Mol Immunol. 2012; 49: 640-648
        • Esparza-Gordillo J.
        • Goicoechea de J.E.
        • Buil A.
        • et al.
        Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.
        Hum Mol Genet. 2005; 14: 703-712
        • Abarrategui-Garrido C.
        • Martinez-Barricarte R.
        • Lopez-Trascasa M.
        • de Cordoba S.R.
        • Sanchez-Corral P.
        Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
        Blood. 2009; 114: 4261-4271
        • Heurich M.
        • Martinez-Barricarte R.
        • Francis N.J.
        • et al.
        Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.
        Proc Natl Acad Sci U S A. 2011; 108: 8761-8766
        • Zipfel P.F.
        • Skerka C.
        FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function.
        Immunol Today. 1999; 20: 135-140
        • Fakhouri F.
        • Roumenina L.
        • Provot F.
        • et al.
        Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.
        J Am Soc Nephrol. 2010; 21: 859-867
        • Martinez-Barricarte R.
        • Pianetti G.
        • Gautard R.
        • et al.
        The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome.
        J Am Soc Nephrol. 2008; 19: 639-646